Invest
Invest in the Future of Cancer Detection
SpotitEarly aims to transform how cancer is detected - developing a simple, non-invasive breath test powered by AI and the extraordinary sense of smell of trained dogs.
Our goal: detect cancer early, when it’s most treatable, and help save lives.
Invest in the Future of Cancer Detection
SpotitEarly aims to transform how cancer is detected - developing a simple, non-invasive breath test powered by AI and the extraordinary sense of smell of trained dogs.
Our
Goal
Detect cancer early, when it’s most treatable, and help save lives.
A Limited-Time Opportunity
Now, there’s a limited-time opportunity for you to join our mission.
Backed by leading VCs and private investors, SpotitEarly is opening the door to new investors.
Accredited investors can invest today.
Regular investors can reserve a spot in our upcoming public round, launching soon.
This is your opportunity to support a life changing innovation and grow with it.
Revolutionizing Cancer Screening
FROM
Multiple tests for different cancers
TO
One test for multiple cancers
.png)
Easy To Use
.png)
At-Home
.png)
Multiple cancer types
.png)
Highly Accurate
Early detection can increase survival rate to as high as 99%
of diagnosed Cancers are found by Recommended Screening
The economic burden of cancer care in the US will exceed to $245B by 2030
Our clinical study demonstrated 94% sensitivity and specificity for early-stage cancer detection
AI + Canines
Fusing AI precision with one of nature’s most intuitive diagnostic tools -unlocking a potential unmatched by any device
Scale
Our proprietary system is a turnkey, high-throughput solution, potentially enabling over 1 million annual tests in each SpotitEarly-powered screening facility
Why Us? Why Now?
DISCLAIMER
The securities referred to in this website may be sold only to accredited investors, which for natural persons, are investors who meet certain minimum annual income or net worth thresholds. These securities are being offered in reliance on an exemption from the registration requirements of the Securities Act and are not required to comply with specific disclosure requirements that apply to registration under the Securities Act. The Securities and Exchange Commission has not passed on the merits of or given its approval to the securities, the terms of the offering, or the accuracy or completeness of any offering materials. The securities are subject to legal restrictions on transfer and resale and investors should not assume that they will be able to resell their securities. Investing in securities involves risk, and investors should be able to bear the loss of their investment.
We at SpotitEarly are committed to saving lives and improving clinical outcomes for everyone, everywhere.
We at SpotitEarly
are committed to saving lives and improving clinical outcomes
for everyone
everywhere
We at SpotitEarly are committed to saving lives and improving clinical outcomes for everyone, everywhere.
Our Values
Why can’t all people around the world adopt regular, hassle-free cancer pre-screening at home, and enjoy life to the fullest?
Currently, despite billions spent on cancer screening, nearly half of the cases are still not detected early enough.
Victory over cancer requires a fresh approach. We looked to nature, with its remarkable capabilities and resilience, and combined it with the power of artificial intelligence.
SpotitEarly’s technology allows more frequent testing of much wider audiences at a fraction of the cost.
We’re bringing the learning power embedded in our system to the forefront of the race against cancer.
Compassion
All humans deserve a better chance at life, and to be spared unnecessary suffering. We strive to preserve their dignity, independence and right to good health.
Accuracy
We uphold the highest standards of reliability, fundamental to our work. Precision and effectiveness in our solutions will lead to better outcomes for individuals.
Innovation
We continuously push the limits of technology to develop cutting-edge solutions for early detection. Only with disruption can we meet new challenges and deliver impactful results.
Canine Care
We truly care for our 4-legged partners’ wellbeing. We provide them the best nutrition, space to exercise, playtime, tons of love, warmth, and their favorite goodies.
FOUNDERS
Roi Ophir
Co-founder, Active Chairman
Jinni: Co founder, CPO & CMO
ArtToGet: Co founder & CEO
Ariel Ben-Dayan
Co-founder, CEO
K-9 unit: Formerly Commander
Hadassah MC: Board member
Ohad Sharon
Co-founder, CSO (Strategy)
Skilled entrepreneur, Senior Executive & High Rank Officer Special Units
Udi Bobrovsky
Co-founder, COO
SelfCare: Co-founder, VP products
MindSense: Co-founder, CEO
LEADERSHIP
Amir Lifshitz
VP of operations
BIOTECHNOLOGY
PRODUCT
CEO
CANINE OPERATION
Amir Lifshitz
VP of operations
BIOTECHNOLOGY
PRODUCT
CEO
Amir Lifshitz
VP of operations
Ari Taulo
Dog Caregiver
Ariel ben Dayan
CEO | Co-founder
Assaf Rabinowicz
CTO
David Levy
Dog Caregiver
Hilla Schaik-Harbour
Lead Regulation manager
Irit Gazit
Director of canine applied research
Itamar Wizegun
Trainer
Liya Schwartzbart
Dog Caregiver
Miia Levy
Lab Technician
Ohad Sharon
CSO | Co-founder
Omer Pinkas
Lab Technician
Reef Einoch Amor
Director of chemical analysis
Roi Ophir
Co-founder | Chairman
Roni Yakir
Office manager
Shlomi Madar
Director of business development NA
Udi Bobrovsky
COO
Vered Fogelman
Lab Technician
Yael Morgan
Head Trainer
Yarden Rosenthal
Lab Technician
Yossi Melamed
VP Canine operation
Zeev Hananis
Data analyst
Tom Birom
Dog Caregiver
